United States · FDA National Drug Code directory
Ilaris
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0734_a09d3635-1735-4ac9-884e-5c49897da6f5
- Product NDC
- 0078-0734
- Form
- INJECTION, SOLUTION
- Composition / generic term
- canakinumab
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20161222
- Source listing expiry
- 20271231
Source-listed ingredients
- CANAKINUMAB — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (0078-0734-61) / 1 mL in 1 VIAL, SINGLE-USE · 0078-0734-61
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →